The abstract is read at the publisher; the summary is JClub's.
Hepatic HRG is suppressed by heparin/PF4 via the FGFR–ERK–Elk1 pathway, and physiological HRG levels markedly reduce thrombus formation under flow conditions.
- Why it matters: HIT mortality is driven by early immune-complex formation and thrombus development, yet the initiating regulatory mechanisms and protective counterpaths remain unclear.
- What they did: Plasma proteomics after repeated heparin dosing over 5 days showed HRG reduction linked to platelet activation; mechanistically, Elk1 directly regulates hepatic HRG transcription, and HRG was tested for effects on platelet activation and immune complexes.
- The result: Physiological HRG inhibited platelet activation, procoagulant activity, spreading, and aggregation, blocked ultralarge PF4-heparin complex formation and KKO binding, and reduced ULIC-triggered NETs and microvascular thrombus formation in vitro and in a mouse model of HIT.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.